Viking Therapeutics (VKTX) Earnings
|
Expand Research on VKTX
| Next EPS Date | 7/29/26 | EPS Growth Rate | -113.8% |
|---|---|---|---|
| Average EPS % Beat Rate | -33.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/29/26  |
Q226 | N/A | -$1.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 4/29/26 | Q126 | -$1.37 | -$1.02 | -$0.35 | N/A | N/A | N/A |  | | Details | |
| 2/11/26 |
Q425 | -$1.38 | -$0.90 | -$0.48 | N/A | N/A | N/A | | | Details | |
| 10/22/25 | Q325 | -$0.81 | -$0.70 | -$0.11 | N/A | N/A | N/A | | | Details | |
| 7/23/25 | Q225 | -$0.58 | -$0.45 | -$0.13 | N/A | N/A | N/A | | | Details | |
| 4/23/25 | Q125 | -$0.41 | -$0.33 | -$0.08 | N/A | N/A | N/A | | | Details | |
| 2/5/25 | Q424 | -$0.32 | -$0.28 | -$0.04 | N/A | N/A | N/A | | | Details | |
| 10/23/24 | Q324 | -$0.22 | -$0.24 | +$0.02 | N/A | N/A | N/A | | | Details |
